Molecular Docking and ADMET Prediction of Selected Neem (Azadirachta indica) Phytochemicals as EGFR Inhibitors: An Integrated In Silico Screening Study
Background: The epidermal growth factor receptor (EGFR) tyrosine kinase is a clinically validated oncology drug target, yet acquired resistance and toxicity limit currently approved EGFR tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib and erlotinib. Azadirachta indica (neem), a plant deeply embedded in South I...